명의 월스트리트 애널리스트에 따르면, NewGenIvf Group Ltd의 매출 추정치는 $에서 $까지입니다.
NewGenIvf Group Ltd의 수익 품질 점수는 얼마인가요?
NewGenIvf Group Ltd의 수익 품질 점수는 A-/59.156532입니다. 이 점수는 수익성, 성장, 현금 창출 및 자본 배분, 레버리지의 네 가지 차원을 기반으로 합니다.
NewGenIvf Group Ltd는 언제 수익을 보고하나요?
NewGenIvf Group Ltd의 다음 수익 보고서는 에 발표될 예정입니다.
NewGenIvf Group Ltd의 예상 수익은 얼마인가요?
월스트리트 애널리스트에 따르면 NewGenIvf Group Ltd의 예상 수익은 $입니다.
NewGenIvf Group Ltd은 수익 기대치를 충족했나요?
NewGenIvf Group Ltd의 최근 수익은 $로, 기대치를 .
주요 통계
이전 종가
$2.01
시가
$2.04
일일 범위
$1.82 - $2.05
52주 범위
$1.52 - $4,440
거래량
40.8K
평균 거래량
194.0K
배당수익률
--
EPS(TTM)
223.07
시가총액
$1.8M
NIVF란 무엇인가요?
NewGenIvf Group Ltd is a TH-based company operating in Health Care Providers & Services industry. The company is headquartered in Bangkok, Bangkok Metropolis and currently employs 76 full-time employees. The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The company specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The company has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.